advancing innovation to save lives

GHTC launches petition calling on world leaders to include R&D in the Global Health Security Agenda

GHTC launched a new online petition calling on world leaders to include clear commitments to strengthening R&D capacity in the 2019-2024 Global Health Security Agenda framework, which is currently under development.
Take Action

Return On Innovation: Learn how global health R&D delivers for your state

Global health R&D matters globally and benefits you locally. Find out how US investments in global health R&D are paying economic and health dividends in your state.
View

Member Spotlight: Aeras

Aeras is a nonprofit organization developing new, effective TB vaccines that are affordable and accessible to all who need them.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Mike Wang
GHTC applauds White House budget proposal

President Obama's fiscal year 2011 budget proposal clearly demonstrates that the White House is committed to R&D and global health issues by increasing funding for several key US agencies. GHTC applauds this commitment to innovation and urges the Obama Administration to continue to bolster and integrate its investment in R&D.

Learn More
PATH/Gabe Bienczycki
Groundbreaking survey of funding for global health R&D released in India

GHTC commends the release of the 2009 Global Funding of Innovation for Neglected Diseases (G-FINDER) survey, created by the George Institute for International Health. The G-FINDER is the only annual global survey of public and private investments in R&D for neglected diseases.

Learn More
View All News & Events

Community Event

United Nations
73rd Session of the UN General Assembly
United Nations
Learn More

Member Event

PATH/Matthew Dakin
Launch of the AMR Challenge
The Bill & Melinda Gates Foundation, U.S. Centers for Disease Control and Prevention, CDC Foundation, PEW Charitable Trusts, UN Foundation, Wellcome Trust
Learn More
View All Events
PATH/Wendy Stone
Research Roundup: US launches biodefense strategy, TB remains world's top infectious killer, and human trials begin for antimalarial drug

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Eric Becker
Research Roundup: Neutralizing Ebola, a prototype to fight the next pandemic, and Zika vaccine trial moves forward

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide